Hepion Pharmaceuticals, Inc.

HEPA · OTC · SIC 2834: Pharmaceutical Preparations
359
SEC Filings

Business Summary

Hepion Pharmaceuticals, Inc. is a medical diagnostic company headquartered in Morristown, New Jersey. Previously focused on chronic liver disease drug therapy via its cyclophilin inhibitor rencofilstat, the company pivoted to diagnostics after halting its ASCEND-NASH clinical trial. It in-licensed diagnostic tests for celiac disease, respiratory multiplex (Covid/Influenza A/B/RSV), H. pylori, and hepatocellular carcinoma from New Day Diagnostics, and licensed liver disease diagnostic assets from Cirna Diagnostics.

Next Earnings

Q2 FY2026 — expected 2026-09-10

Key Facts from Earnings Calls

TypeSubjectDetailQuarter
topic_mentionHEPAdiscussed_in_filing Cybersecurity
topic_mentionHEPAdiscussed_in_filing Trusted Computing
topic_mentionHEPAdiscussed_in_filing Blockchain & Crypto
topic_mentionHEPAdiscussed_in_filing Regulation
topic_mentionHEPAdiscussed_in_filing Healthcare & Bio
topic_mentionHEPAdiscussed_in_filing Sovereign & Government
topic_mentionHEPAdiscussed_in_filing Cybersecurity
topic_mentionHEPAdiscussed_in_filing Trusted Computing
topic_mentionHEPAdiscussed_in_filing Blockchain & Crypto
topic_mentionHEPAdiscussed_in_filing Regulation
topic_mentionHEPAdiscussed_in_filing Healthcare & Bio
topic_mentionHEPAdiscussed_in_filing Sovereign & Government
topic_mentionHEPAdiscussed_in_filing Cybersecurity
topic_mentionHEPAdiscussed_in_filing Trusted Computing
topic_mentionHEPAdiscussed_in_filing Blockchain & Crypto
topic_mentionHEPAdiscussed_in_filing Regulation
topic_mentionHEPAdiscussed_in_filing Healthcare & Bio
topic_mentionHEPAdiscussed_in_filing Sovereign & Government
topic_mentionHEPAdiscussed_in_filing Cybersecurity
topic_mentionHEPAdiscussed_in_filing Trusted Computing

Annual Reports (10-K)

FiledPeriodAccessionSourceFull Text
2026-03-122025-12-310001493152-26-009755EDGAR56K words
2025-04-082024-12-310001641172-25-003250EDGAR—
2024-04-162023-12-310001583771-24-000003EDGAR—
2023-04-102022-12-310001583771-23-000003EDGAR—
2022-04-082021-12-310001583771-22-000003EDGAR—
2021-03-312020-12-310001558370-21-003836EDGAR—
2020-05-142019-12-310001104659-20-061587EDGAR—
2019-03-142018-12-310001104659-19-014652EDGAR—
2017-09-282017-06-300001104659-17-059696EDGAR—
2016-09-282016-06-300001104659-16-147194EDGAR—

Quarterly Reports (10-Q)

FiledPeriodAccessionSourceFull Text
2025-11-122025-09-300001493152-25-021864EDGAR21K words
2025-08-142025-06-300001641172-25-023944EDGAR—
2025-05-192025-03-310001641172-25-011534EDGAR—
2024-11-142024-09-300001493152-24-046002EDGAR—
2024-08-132024-06-300001493152-24-031582EDGAR—
2024-05-212024-03-310001628280-24-024560EDGAR—
2023-11-202023-09-300001583771-23-000013EDGAR—
2023-08-142023-06-300001583771-23-000010EDGAR—
2023-05-122023-03-310001583771-23-000007EDGAR—
2022-11-142022-09-300001583771-22-000012EDGAR—
2022-08-152022-06-300001583771-22-000009EDGAR—
2022-05-162022-03-310001583771-22-000006EDGAR—

Recent Current Reports (8-K)

FiledAccessionSourceFull Text
2026-03-180001493152-26-011222EDGAR1K words
2026-03-030001493152-26-008650EDGAR—
2026-01-150001493152-26-002428EDGAR—
2025-06-300001641172-25-017037EDGAR—
2025-06-120001641172-25-014858EDGAR—
2025-06-090001641172-25-014320EDGAR—
2025-05-300001641172-25-013048EDGAR—
2025-05-120001641172-25-009744EDGAR—
2025-05-060001641172-25-008761EDGAR—
2025-04-170001641172-25-005241EDGAR—

359 total filings indexed. 327 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR

Sector Peers

SXTP — 60 DEGREES PHARMACEUTICALS, INC. ABT — ABBOTT LABORATORIES ABEO — ABEONA THERAPEUTICS INC. ABVC — ABVC BIOPHARMA, INC. ACAD — ACADIA PHARMACEUTICALS INC ACTU — ACTUATE THERAPEUTICS, INC. ADCT — ADC Therapeutics SA ADIL — ADIAL PHARMACEUTICALS, INC.

Tags

medical-diagnostics chronic-liver-disease european-union-diagnostic-markets celiac-disease-diagnostics respiratory-disease-diagnostics hepatocellular-carcinoma-diagnostics ce-mark-(european-conformity-for-medical-devices)

Company Identity

CIK0001583771
TickerHEPA
ExchangeOTC
SIC2834: Pharmaceutical Preparations
IncorporatedDE
HeadquartersMorristown, New Jersey

Get More Data

This is the free public profile. For structured JSON with full provenance chain, use the API:

JSON Profile Stock Quote AI Readiness Report
Origin Provenance
page leaf: 66dd55c3cff60b156f79ac2967aa7183df4763649d817822c7a3b0603d13bf29
parent: a8fe333ab1d3a96ce887be30c497d84772a51ba4c86fefb13517674af58b8d63
content hash: 677cde7117cf6b595a74fd768901a45dc360e068673fc576d021a2f8cdc4d312
signed: 2026-04-13T04:45:28.391Z
sources: 22 verified data leaves
chain: SEC.gov PEM → origin.rootz.global extraction → this page
verify: sha256(content_hash + parent + timestamp) = leaf